Position history for BlackRock, Inc.'s holdings in ATEA PHARMACEUTICALS INC
BlackRock, Inc. holds 8.4M shares of AVIR (ATEA PHARMACEUTICALS INC), worth $45.4M as of 2026-Q1. The position was decreased (-0.7% shares). AVIR represents 0.0% of BlackRock, Inc.'s portfolio.
Current Value
$45.4M
Current Shares
8.4M
Total Value Change
+$15M
Total Shares Change
-626,744
Other major holders of AVIR: RA CAPITAL MANAGEMENT, L.P., ADAGE CAPITAL PARTNERS GP, L.L.C.
Decreased |
| 8.4M |
-0.7% |
| $45.4M |
| 0.0% |
| $4.82 |
0 |
| 2025-Q4 | Increased | 8.5M | +0.4% | $30.3M | 0.0% | $3.55 | 29 |
| 2025-Q3 | Decreased | 8.5M | -2.4% | $24.5M | 0.0% | $2.92 | 0 |
| 2025-Q2 | Decreased | 8.7M | -3.1% | $31.2M | 0.0% | $3.45 | 0 |
| 2025-Q1 | Decreased | 8.9M | -1.3% | $26.7M | 0.0% | $2.93 | 0 |
| 2024-Q4 | New | 9.1M | - | $30.4M | 0.0% | $3.33 | 40 |